Kohei Osakada
Overview
Explore the profile of Kohei Osakada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taninobu N, Kubo S, Oka S, Nishiura N, Sasaki K, Matsushita S, et al.
Circ J
. 2025 Mar;
PMID: 40044150
Background: Hemodialysis (HD) is associated with adverse cardiovascular events after percutaneous coronary intervention (PCI). Although the ultrathin strut biodegradable polymer sirolimus-eluting stent (ultrathin strut BP-SES) has had better results in...
2.
Fujita M, Kubo S, Mushiake K, Nishiura N, Ono S, Osakada K, et al.
JACC Cardiovasc Interv
. 2025 Feb;
18(4):529-531.
PMID: 40010922
No abstract available.
3.
Sawayama Y, Sasaki K, Taninobu N, Ikuta A, Osakada K, Kubo S, et al.
JACC Asia
. 2025 Jan;
5(1):46-55.
PMID: 39886189
Background: Intravascular imaging (IVI) complements coronary angiography and may help prevent coronary artery perforation (CAP) during percutaneous coronary intervention (PCI). Objectives: The authors evaluated whether IVI-guided PCI is associated with...
4.
Taniguchi T, Morimoto T, Takeji Y, Shirai S, Ando K, Tabata H, et al.
JACC Cardiovasc Interv
. 2024 Dec;
18(4):471-487.
PMID: 39708011
Background: Low-gradient (LG) aortic stenosis (AS) has not been fully characterized compared with high-gradient (HG) AS in terms of cardiac damage, frailty, aortic valve calcification, and clinical outcomes. Objectives: The...
5.
Yamamoto K, Takeji Y, Taniguchi T, Morimoto T, Shirai S, Kitai T, et al.
Circ J
. 2024 Dec;
PMID: 39694497
Background: There is a paucity of data on safety of calcium channel blockers (CCB) in patients with severe aortic stenosis (AS) and hypertension. Methods And Results: Among 2,460 patients with...
6.
Mushiake K, Kubo S, Ono S, Maruo T, Nishiura N, Osakada K, et al.
Circ Cardiovasc Interv
. 2024 Dec;
17(12):e014420.
PMID: 39689186
Background: A small mitral valve area (MVA) is one of the challenging anatomies for transcatheter edge-to-edge repair (TEER) for mitral regurgitation, but the relationship between baseline MVA and clinical outcomes...
7.
Sawayama Y, Sasaki K, Taninobu N, Ikuta A, Osakada K, Kubo S, et al.
Catheter Cardiovasc Interv
. 2024 Dec;
105(2):464-474.
PMID: 39659069
Background: Reversing heparin when managing coronary artery perforation (CAP) during percutaneous coronary intervention (PCI) can provide hemostasis but may cause coronary thrombosis if a device is still present in a...
8.
Takeji Y, Taniguchi T, Morimoto T, Shirai S, Kitai T, Tabata H, et al.
Cardiovasc Interv Ther
. 2024 Nov;
40(1):152-163.
PMID: 39604671
There was a scarcity of data evaluating variations in treatment approaches and clinical outcomes for severe aortic stenosis (AS) between medical centers with and without availability of transcatheter aortic valve...
9.
Ono S, Kubo S, Maruo T, Nishiura N, Mushiake K, Osakada K, et al.
EuroIntervention
. 2024 Nov;
20(22):1430-1441.
PMID: 39552478
Background: Little is known about the effects of left ventricular ejection fraction (LVEF) worsening after transcatheter edge-to-edge valve repair (TEER) for mitral regurgitation (MR). Aims: This study investigated the predictors...
10.
Nishiura N, Kubo S, Fujita M, Mushiake K, Ono S, Osakada K, et al.
Cardiovasc Interv Ther
. 2024 Jun;
39(4):468-478.
PMID: 38833119
The MitraClip G4 device has controlled gripper actuation (CGA) system, which allows the anterior and posterior grippers operate separately in transcatheter edge-to-edge repair (TEER). We investigated the indications and outcomes...